Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone

References

• Levy B, Paulozzi L, Mack KA, et al. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012. Am J Prev Med. 2015;49:409–413.
   PubMed Web of Science ®Google Scholar
• Kuo YF, Raji MA, Chen NW, et al. Trends in opioid prescriptions among part d medicare recipients from 2007 to 2012. Am J Med. 2016;129:221–230.
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65:1–49. Mar 18
   PubMed Web of Science ®Google Scholar
• Guy GP, Jr., Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66:697–704.
   PubMed Web of Science ®Google Scholar
• Schultz S, Chamberlain C, Vulcan M, et al. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center. J Opioid Manag. 2016;12:119–122.
   PubMedGoogle Scholar
• Raji MA, Kuo YF, Adhikari D, et al. Decline in opioid prescribing after federal rescheduling of hydrocodone products. Pharmacoepidemiol Drug Saf. 2018;27:513–519.
   PubMed Web of Science ®Google Scholar
• Seago S, Hayek A, Pruszynski J, et al. Change in prescription habits after federal rescheduling of hydrocodone combination products. Proc (Bayl Univ Med Cent). 2016;29:268–270.
   PubMedGoogle Scholar
• Oehler EC, Day RL, Robinson DB, et al. Has the rescheduling of hydrocodone changed ED prescribing practices?. Am J Emerg Med. 2016;34:2388–2391.
   PubMed Web of Science ®Google Scholar
• Haynes A, Kleinschmidt K, Forrester MB, et al. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone. Clin Toxicol. 2016;54:434–440.
   PubMed Web of Science ®Google Scholar
• Hassamal S, Miotto K, Dale W, et al. Tramadol: understanding the risk of serotonin syndrome and seizures. Am J Med. 2018;131:1382.e1–1382.e6.
   Web of Science ®Google Scholar
• Bronstein AC, Spyker DA, Cantilena LR, Jr, et al. 2006 Annual report of the american association of poison control centers’ national poison data system (NPDS). Clin Toxicol. 2007;45:815–917.
   PubMed Web of Science ®Google Scholar
• Gummin DD, Mowry JB, Spyker DA, et al. 2016 annual report of the american association of poison control centers’ national poison data system (NPDS): 34th annual report. Clin Toxicol. 2017;55:1072–1252.
   PubMed Web of Science ®Google Scholar
• Gong L, Stamer UM, Tzvetkov MV, et al. PharmGKB summary: tramadol pathway. Pharmacogenet Genom. 2014;24:374–380.
   PubMed Web of Science ®Google Scholar
• Stamer UM, Musshoff F, Kobilay M, et al. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clin Pharmacol Ther. 2007;82:41–47.
   PubMed Web of Science ®Google Scholar
• Labate A, Newton MR, Vernon GM, et al. Tramadol and new-onset seizures. Med J Aust. 2005;182:423.
   Web of Science ®Google Scholar
• Petramfar P, Haghighi A. Tramadol induced seizure: report of 106 patients. Iran Red Crescent Med J. 2010;12:49.
   Web of Science ®Google Scholar
• Sansone RA, Sansone LA. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 2009;6:17–21.
   PubMedGoogle Scholar
• Taghaddosinejad F, Mehrpour O, Afshari R, et al. Factors related to seizure in tramadol poisoning and its blood concentration. J Med Toxicol. 2011;7:183–188.
   PubMedGoogle Scholar
• Shadnia S, Soltaninejad K, Heydari K, et al. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol. 2008;27:201–205.
   PubMed Web of Science ®Google Scholar
• Eizadi-Mood N, Ozcan D, Sabzghabaee AM, et al. Does naloxone prevent seizure in tramadol intoxicated patients? Int J Prev Med. 2014;5:302–307.
   PubMedGoogle Scholar
• Talaie H, Panahandeh R, Fayaznouri M, et al. Dose-independent occurrence of seizure with tramadol. J Med Toxicol. 2009;5:63–67.
   PubMedGoogle Scholar
• Marquardt KA, Alsop JA, Albertson TE. Tramadol exposures reported to statewide poison control system. Ann Pharmacother. 2005;39:1039–1044.
   PubMed Web of Science ®Google Scholar
• Shadnia S, Brent J, Mousavi-Fatemi K, et al. Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients. Basic Clin Pharmacol Toxicol. 2012;111:133–136.
   PubMed Web of Science ®Google Scholar
• Jick H, Derby LE, Vasilakis C, et al. The risk of seizures associated with tramadol. Pharmacotherapy 1998;18:607–611.
   PubMed Web of Science ®Google Scholar
• Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth Analg. 2005;100:1400–1405.
   PubMed Web of Science ®Google Scholar
• Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res. 1983;287:197–210.
   PubMedGoogle Scholar
• Shafaroodi H, Samini M, Moezi L, et al. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology. 2004;47:390–400.
   PubMed Web of Science ®Google Scholar
• Hantson PE. Toxicant-induced seizures. In: Brent J, Burkhart K, Dargan P, et al., editors. Critical care toxicology: diagnosis and management of the critically poisoned patient. New York (NY): Springer; 2017. p. 447–473.
   Google Scholar
• Burtscher J, Schwarzer C. The opioid system in temporal lobe epilepsy: functional role and therapeutic potential. Front Mol Neurosci. 2017;10:245.
   PubMed Web of Science ®Google Scholar
• Gilbert PE, Martin WR. Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice. J Pharmacol Exp Ther. 1975;192:538–541.
   PubMed Web of Science ®Google Scholar
• Prow NA, Irani DN. The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp Neurol. 2007;205:461–470.
   PubMed Web of Science ®Google Scholar
• Saidi H, Ghadiri M, Abbasi S, et al. Efficacy and safety of naloxone in the management of postseizure complaints of tramadol intoxicated patients: a self-controlled study. Emerg Med J. 2010;27:928–930.
   PubMed Web of Science ®Google Scholar
• Yang L, Li F, Ge W, et al. Protective effects of naloxone in two-hit seizure model. Epilepsia. 2010;51:344–353.
   PubMed Web of Science ®Google Scholar
• Lagard C, Malissin I, Indja W, et al. Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat. Clin Toxicol. 2018;56:737–743.
   PubMed Web of Science ®Google Scholar
• Raffa RB, Stone DJ. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. J Pharmacol Exp Ther. 2008;325:500–506.
   PubMed Web of Science ®Google Scholar
• Farrugia LA, Rhyee SH, Calello DP, et al. The toxicology investigators consortium case registry-the 2016 experience. J Med Toxicol. 2017;13:203–226.
   PubMed Web of Science ®Google Scholar
• Wax PM, Kleinschmidt KC, Brent J, et al. The toxicology investigators consortium (ToxIC) registry. J Med Toxicol. 2011;7:259–265.
   PubMedGoogle Scholar
• Rhyee SH, Farrugia L, Campleman SL, et al. The toxicology investigators consortium case registry–the 2014 experience. J Med Toxicol. 2015;11:388–409.
   PubMed Web of Science ®Google Scholar
• Farrugia LA, Rhyee SH, Campleman SL, et al. The toxicology investigators consortium case registry-the 2015 experience. J Med Toxicol. 2016;12:224–247.
   PubMed Web of Science ®Google Scholar
• Ryan NM, Isbister GK. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol. 2015;53:545–550.
   PubMed Web of Science ®Google Scholar
• Almalki M, Almulhim K, Hon S, et al. Abstracts from the American College of Medical Toxicology (ACMT) Annual Scientific Meeting: tramadol exposures reported to NPDS. J Med Toxicol. 2017;13:42.
   Web of Science ®Google Scholar
• Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 2002;3:229–243.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang H, He F, et al. Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population. Eur J Clin Pharmacol. 2006;62:927–931.
   PubMed Web of Science ®Google Scholar
• Gan SH, Ismail R, Wan Adnan WA, et al. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics. Mol Diagn Ther. 2007;11:171–181.
   PubMed Web of Science ®Google Scholar
• Gan SH, Ismail R, Wan Adnan WA, et al. Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects. J Pharm Biomed Anal. 2002 ;30:189–195. 5
   PubMed Web of Science ®Google Scholar
• Kahn LH, Alderfer RJ, Graham DJ. Seizures reported with tramadol. JAMA. 1997;278:1661.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997;35:361–364.
   PubMed Web of Science ®Google Scholar
• Rehni AK, Singh I, Kumar M. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent gamma-aminobutyric acid inhibitory pathway. Basic Clin Pharmacol Toxicol. 2008;103:262–266.
   PubMed Web of Science ®Google Scholar
• Miura M, Saino-Saito S, Masuda M, et al. Compartment-specific modulation of GABAergic synaptic transmission by mu-opioid receptor in the mouse striatum with green fluorescent protein-expressing dopamine islands. J Neurosci. 2007;27:9721–9728.
   PubMed Web of Science ®Google Scholar
• Dingledine R, Iversen LL, Breuker E. Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol. 1978;47:19–27.
   PubMed Web of Science ®Google Scholar
• Svensson AI, Berntsson A, Eirefelt M, et al. Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes. J Neural Transm (Vienna). 2000;107:261–270.
   PubMed Web of Science ®Google Scholar
• Gruol DL, Barker JL, Smith TG. Naloxone antagonism of GABA-evoked membrane polarizations in cultured mouse spinal cord neurons. Brain Res. 1980;198:323–332.
   PubMed Web of Science ®Google Scholar
• Gardner JS, Blough D, Drinkard CR, et al. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy. 2000;20:1423–1431.
   PubMed Web of Science ®Google Scholar